Exchange: NASDAQ·Updated 07:43 PM EDT
PHVS logo

PHVS Pharvaris NV

$36.00
$0.41
(1.15%)
Today
Closed $35.25
$0.75
(2.13%)
After Hours
Reported EarningsAug 12
Mkt Cap$2.49B
Vol483,983.00

About PHVS

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
56

Bullish Sentiment

How do you feel about PHVS?

Advertisement|Remove ads.